Karo Pharma AB diskutieren
Karo Pharma AB
WKN: A14YW4 / Symbol: KARO / Name: Karo Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
5,44 €
-0,18 %
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Raymond James from $27.00 to $30.00. They now have an "outperform" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Morgan Stanley from $37.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $34.00 price target on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Raymond James from $30.00 to $26.00. They now have an "outperform" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Raymond James from $26.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Morgan Stanley from $34.00 to $31.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $31.00 price target on the stock.
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its price target raised by analysts at Morgan Stanley from $31.00 to $37.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
Neueste Beiträge
Royal_Bank_of_Canada in Intra-Cellular Therapies Inc. diskutieren